No Data
No Data
Scotiabank Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Cuts Target Price to $430
TD Cowen Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $525
BofA Securities Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating
Vertex Pharmaceuticals (VRTX) Receives a Buy From Bank of America Securities
TD Cowen Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Is Maintained at Overweight by JP Morgan